SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950162-04-000241
Filing Date
2004-02-19
Accepted
2004-02-19 17:20:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 dor13dano4021904.txt SC 13D/A 16515
  Complete submission text file 0000950162-04-000241.txt   18535
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-39976 | Film No.: 04617049
SIC: 2834 Pharmaceutical Preparations

Mailing Address 102 ST JAMES COURT FIETSS SMITH FL BERM D0 9999999999
Business Address
ELAN PHARMACEUTICAL INVESTMENTS LTD (Filed by) CIK: 0001279105 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231